UK: +44 (0) 1283 753 220
US: +1 908 829 4146
Bionical, a partner to the pharmaceutical and biotech industry has announced Jason Tape has joined the company as Director, Business Development - Clinical. The statement comes after Bionical announced they acquired Emas Pharma, a global, full-service Clinical Research Organization, in the late fall of 2016. With his strong clinical background, Jason will be uniquely positioned to expand our presence in the US, focusing on developing strategic partnerships with Pharma and Biotech companies.
Growing the Bionical team within the US, allows us to better serve our clients and their clinical development needs. Bringing together our CRO and CTS service offerings has been strategically designed to ensure we fit with the company’s mission to improve patient outcomes. It is this approach that enables us to design tailored solutions for our clients.
On becoming part of Bionical, Jason says, “I’m looking forward to being part of a company that is patient focused. The clinical arena sets the pace for new approaches and medicines that can help improve patient livelihood. I’m excited to work alongside our clients at Bionical to develop new and innovative solutions that help accomplish this.”
Bionical Executive Director of Business Development, Jonathan Waring Hughes states, “We look forward to Jason working alongside our team to develop tailored solutions for our clients’ clinical development plans. Jason’s robust portfolio and background made him a perfect fit for this role.”
Jason’s full profile can be accessed here: https://www.linkedin.com/in/jason-tape-7b58a737/
All rights reserved © 2019 Bionical Ltd.